Moon Kil Woong is currently a VP at a SME. Previously he was a tech stock consultant, VP of Research at ING, and sell side Director at Crédit Agricole Indosuez. Moon Kil Woong has a Masters in Public Administration from SJSU.
He contributes to both TalkMarkets and Seeking Alpha. You ...
more Moon Kil Woong is currently a VP at a SME. Previously he was a tech stock consultant, VP of Research at ING, and sell side Director at Crédit Agricole Indosuez. Moon Kil Woong has a Masters in Public Administration from SJSU.
He contributes to both TalkMarkets and Seeking Alpha. You can see his articles on TalkMarkets
here, and on Seeking Alpha
here.
less
Latest Comments
CytoDyn's Update Provides A Clear Path Towards Approval With Up-Listing Potential Still In The Cards
Its sad what was done with this stock. It goes to show how any given stock has unknown things and is unpredictable. That said, I am still hopeful and am waiting for traction and positive news.
PLX Upcoming Volatility Creates Opportunity
There is plenty of potential in this small cap. Unfortunately like all the small caps there has been negative sentiment for term for quite some time. Hopefully this will go away along with positive news.
Is There A Light At The End Of The Tunnel For A COVID-19 Therapeutic?
Anne thanks for the question. I'm waiting on solid news due to short speculation that has hurt this stock despite continues progress. It appears the world is becoming aware that they need more that just a vaccine for Covid. Whether CYDY will be part of their solution gives this plenty of upside. Its shocking to see this stock trading where it is.
CytoDyn's Update Provides A Clear Path Towards Approval With Up-Listing Potential Still In The Cards
I'm unsure whether the recent bump in the stock is a relief rally or up on cancer and other news of theirs. I think the bulls are still waiting for news to sink their teeth into.
Lose Less
Sadly bond rates are so low the upside it vary limited and the risk of inflation growing making them simple losses is growing as well. It's not your regular cycle by no means.
Is There A Light At The End Of The Tunnel For A COVID-19 Therapeutic?
Philippines Approval
www.globenewswire.com/.../...COVID-19-Patient.html
Is There A Light At The End Of The Tunnel For A COVID-19 Therapeutic?
Here's another article clearing up the science in the recent trial.
seekingalpha.com/.../4414628-new-look-cytodyn-stock-severe-to-critical-covid-19-trial
April 2021 Monthly
At least in the US the spending will be a lower percentage and it will go to things that will accelerate the economy more. Hopefully, things will be better next year. The focus should not be on balancing the budget but getting thing back on track. The economic error was before not balancing the budget and saving while in better times.
VistaGen Is Prepared For 2021 Fueled By Recent Analyst Upgrades And Large Institutional Buyers
Here are some article to help look at the news in perspective:
insiderfinancial.com/.../181182/
Is There A Light At The End Of The Tunnel For A COVID-19 Therapeutic?
This article clarifies and puts the results in perspective. I too am disappointed in the stocks reaction to decent news.
insiderfinancial.com/.../181154/